Clinically, glycopyrrolate is commonly co-administered with neostigmine during reversal of neuromuscular blockade to prevent bradycardia and reduce airway secretions (typical ratio: 0.2 mg glycopyrrolate per 1 mg neostigmine)
High expression of GT provides cells with greater quantities of cysteine through the breakdown of extracellular GSH (Gerber and Thung, 1980
Finding Refine by Tulsi and the Refine Her program was like finally having someone actually understand the problem instead of dismissing it
is supported by an MRC Skills Development Fellowship award (MR/S019332/1)
Signs include feeling heavy or tired, dry mouth, irritability, or feeling "toxic" or not quite right

Stronger Evidence: GHK-Cu: Clinical studies showing collagen increase, wound healing acceleration Matrixyl: Published studies demonstrating wrinkle reduction Multiple in vitro studies confirming mechanisms Moderate Evidence: Snap-8, Argireline: Manufacturer studies and some independent research Clinical observations support efficacy for expression lines Recent Clinical Data (2024-2025): Bioactive collagen peptides: 19.20% increase in dermal thickness after 12 weeks LMW collagen peptides: 46% wrinkle volume reduction in 6 weeks New peptides showing 73% improvement in sagging, 100% fine-line improvement in trials Limitations: Most peptides lack large-scale, independent clinical trials Effects are modest compared to injectable treatments Consistent, long-term use required Individual responses vary Realistic Expectation: Peptides produce measurable but gradual improvements over timethey don't replace procedures but can complement them